Breast Cancer Screening in China for Foreigners: Mammograms, Biopsy and the Realistic Pathway

Eight Forty in the Breast Clinic: What a Foreign Patient Actually Walks Into

The waiting room opens at half past seven. By ten past eight there are twenty people in it, and only two of them are sitting with a coat over their arms the way you would if you had flown in the night before. The patient I am thinking about arrived at the outpatients’ entrance with a printed page of questions someone had helped her translate the evening before — family history, age of first child, whether she had ever had a breast biopsy, whether anything hurt when she pressed. She had a Russian passport, a Shenzhen address on a friend’s sofa, and a lump she had found in the shower two weeks earlier that her sister had told her not to worry about.

Nothing dramatic happened in the next four hours. She registered at the machine in the lobby with her passport, had a photograph taken, was given a paper folder with a number clipped to it, walked up to the third floor, listened to a nurse read out the ultrasound results, waited another forty minutes, saw the surgeon for eleven minutes, and left with a written instruction to come back on a Thursday for a mammogram. That is the whole shape of it. Breast care in a Chinese public hospital is not a dramatic scene. It is a sequence of small, boring, predictable steps, and most foreign patients get those steps wrong in the same handful of places — wrong hospital, wrong department name, wrong assumption about who reads the images, wrong idea about what happens to the slides afterwards.

This article is about those steps. It is written for foreign women who are already in China, or planning to come, and who need a breast screening or a further look at a breast finding. It also covers what happens if the work-up finds something, because a screening article that stops at “here is a mammogram machine” is not much use to someone whose report says BI-RADS 4. I will write about the process in the sense of mechanics: which department to book, what each test actually involves, how long the waits really are, roughly what it costs, and what you can take home with you. I will not write about outcomes, and I will not suggest that any hospital or any test can promise a result. A biopsy tells you what a piece of tissue is. It does not tell you how the next ten years will go, and no competent surgeon in China or anywhere else will let a brochure imply otherwise.

Who This Article Is For, and What “Screening” Means Here

Four groups of readers find their way to this page, and they need slightly different things.

The first is the expat in Shenzhen, Guangzhou, Beijing or Shanghai who is forty-five or older and has never had a screening mammogram, mostly because a screening mammogram was never offered to her where she came from. The second is the woman in her thirties with a family history — a mother, a sister, an aunt — who has read enough on the internet to be worried and wants to know what a Chinese public hospital can actually do. The third is the medical tourist who comes to China for a specific procedure and, while she is here, wants the rest of her work-up done in the same trip. The fourth is the carer, the daughter, the husband, who is the one holding the passport and the phone. If a full health package rather than a single breast question is what you are after, our women’s health screening China page covers the wider exam and what usually turns up in it.

“Screening” and “diagnostic” mean different things here, and the distinction matters because it changes both the price and the wait.

Screening means looking at a breast that has no symptoms, in someone with no known problem, to try to find something before it becomes obvious. In China this work is embedded in public health programmes run through community health centres for Chinese residents, and the population targets in those programmes are set by the National Health Commission. A foreign resident who does not hold Chinese basic health insurance generally is not part of that system, so she will pay for her imaging as a private outpatient. cancer screening China foreign patients in this guide’s sister pages walks through how early detection is organised in this country, because a breast question is usually one branch of a much bigger system.

Diagnostic means someone has a symptom, a finding, or a suspicious result from somewhere else, and the hospital is investigating it. That is a different booking, a different fee schedule, and usually a faster turnaround, because the clinical question is specific. A forty-one-year-old with a lump is not a screening patient. She is a diagnostic patient, and the ultrasound comes first regardless of her age.

One thing to sort out early: China has no dedicated medical visa category. If you are travelling here for an investigation or treatment, the practical route is usually a business visa, a private-affairs visa or a tourist visa, depending on your nationality and how you intend to enter. My colleague wrote the full version of that somewhere else, but the short version is that the visa and the medicine are two separate problems and you should not let one block the other.

Where Breast Care Lives: the Combined Thyroid and Breast Clinic

The first thing that surprises people is the department name. In many Chinese public hospitals, thyroid conditions and breast conditions share one surgical department. You will see it on the appointment board as a single heading, and the English translation on the kiosk may read “Thyroid and Breast Surgery” or, more often, something obviously machine-generated like “Endocrine Breast”. If you searched for “breast surgery” and found nothing, this is usually why.

The logic is not silly. Both organs sit in the front of the neck and chest, both need the same radiology, both end up needing a surgeon who can do an axillary node dissection as comfortably as a thyroidectomy, and both generate a lot of benign disease that keeps the same clinic busy all week. A single combined clinic also means a patient with a nodule in each place does not make two appointments in two buildings.

But the combination creates a real problem for a foreign patient: the waiting list is shared. A Tuesday morning specialist clinic at a busy tertiary hospital in Shenzhen or Guangzhou can carry thirty patients, and half of them are thyroid ultrasound cases. Build in forty minutes for registration and queueing and an eleven-minute consultation, and the arithmetic gets uncomfortable. Ask the registration nurse directly: “Is this the breast clinic or the thyroid clinic today?” If it is a combined session and your problem is breast, you may be asked to return on the breast-specific afternoon. In my experience asking that single question saves an hour.

There are also two kinds of clinic inside the department, and the difference is not hype:

• A general specialist clinic (zhuan-jia men-zhen, often translated as “expert clinic”) where you see a consultant surgeon with a fairly full list. Good if you need your history taken properly and a full bilateral examination.
• A disease-specific clinic (zhuan-bing men-zhen, roughly “specialist disease clinic”, sometimes listed for breast nodules or breast cancer follow-up). Shorter list, more repetitive, often booked weeks out.
• And, increasingly, a foreign-patient or international-services desk in the bigger urban hospitals, which can book a combined slot with radiology and surgery in the same week. This is worth asking about on the phone before you arrive.

Choosing where to go depends on what you are doing. For a first look at a lump or a dense breast under forty, a large general hospital with solid radiology is the right call — the imaging matters more than the surgeon at that stage. If the work-up subsequently finds something, the question changes to “which cancer centre treats this”, and that is a different list of names entirely, which I will come to. A lower-tier hospital can do a screening ultrasound competently, but a suspicious finding there often becomes a referral with the imaging attached, and you should insist on getting a copy of that imaging before you leave.

The First Appointment: History, Exam, and Why Ultrasound Comes First

Registration is the least glamorous and most important hour of the whole thing. Take your passport. Not a photo of it, not a copy — the original. Most tertiary hospitals in the major cities will accept a foreign passport as the patient identity at the self-service kiosk, print a plastic card with your photograph on it, and let that card act as your login for the rest of the visit. Some smaller hospitals still want a Chinese phone number for the system; if you do not have one, ask the international services desk or arrive with a Chinese friend who can register on your behalf, because without an identity match you will be rebooked.

The consultation itself usually runs like this. A nurse or a triage doctor takes the history first: age, whether it is your first visit, when you found the lump, whether it changes with your cycle, any discharge, any previous biopsy, any previous radiation to the chest, hormone use, pregnancy or breastfeeding, and a family history that includes not just breast cancer but ovarian, uterine, thyroid and colon cancer, because the surgeon is building a picture of your lifetime risk rather than just today’s finding.

Then the physical exam, done standing and then lying down, both breasts, compared with the other side, checking the axilla. A surgeon doing this properly spends six to ten minutes. If you get four minutes and nobody touches your axilla, ask for the nodes to be checked; that is the part patients forget is part of the exam.

Then the imaging order. And here is the thing that surprises most foreign patients who come from a Western screening system: in Chinese practice, a young woman with a dense breast usually has ultrasound first, not mammography. The reason is technical and boring. Asian breasts are typically denser — more fibroglandular tissue, less fat — and dense tissue is exactly the thing that makes a mammogram harder to read, because a lump and a dense patch can look alike on a compressional image. Ultrasound sees a dense breast fine. So the sequence for a woman in her thirties with a lump is: high-frequency ultrasound of both breasts plus the axilla, written up in BI-RADS terms, and mammography only if the ultrasound is incomplete, the age warrants it, or the surgeon wants a second opinion from a different modality.

For a woman in her fifties with no symptoms, the order usually flips: the surgeon wants a mammogram, because calcifications — the tiny deposits that are the earliest visible hint of some lesions — are essentially invisible on ultrasound. So the honest answer to “ultrasound or mammogram first?” is: it depends on your age, your density and your symptom, and a good surgeon will tell you which one she wants and why in about thirty seconds. If she does not, that is a question worth asking.

Bring whatever you already have. A previous mammogram, a previous ultrasound report, an MRI report from home, a CD or a USB stick with DICOM images. Chinese hospitals keep their own images on a picture-archiving system and can usually pull your earlier studies if you are a returning patient, but a first-time visitor has no history in their system, and re-doing a mammogram you had six months ago in another country is a waste of both your time and your money. Write the home report’s date and hospital on a slip of paper in English and Chinese. That slip is worth more than the report itself.

Mammography in China: Digital Units, Tomosynthesis and AI Reading Aids

Chinese radiology departments invested heavily in digital breast imaging through the 2010s, and the equipment in a province-level tertiary hospital is generally modern by any standard. The machines are the same names you will see anywhere: Hologic, Siemens Healthineers, GE HealthCare, Philips, and a growing number of domestic units from makers such as United Imaging and Mindray, cleared by the National Medical Products Administration like everything else sold in China.

Two variables change your experience, and neither is visible from the waiting room.

The first is whether the unit does tomosynthesis, which is digital breast tomosynthesis — the “3D” mammogram. Instead of one flat compressed image per view, the machine rotates a short arc and reconstructs a stack of thin slices, which lets the radiologist look through the dense tissue rather than at it. It adds a few seconds per view and a modest amount of extra dose. If you have a dense breast, or a finding that was ambiguous on a two-view exam, ask the radiology desk whether tomosynthesis is available and whether your study needs it. It is not universal, and “the machine in this room does it” is the answer you want rather than “we can send you to another campus”.

The second is whether the readings are computer-assisted. Most Chinese hospitals in major cities now use AI triage software that marks up suspicious areas on the image before the radiologist opens the case, which speeds up reading and, in published comparisons, has reduced the number of studies a busy reader needs to look at closely. This is not a robot diagnosing you. It is a second pair of eyes that never gets tired, and the radiologist signs the report. If you want to understand what is happening to your images, look at the workstation screen while you wait — a lot of hospitals let the patient sit with a technologist for a minute and see the compression and the positioning, which is useful if you have had a bad mammogram elsewhere and want to compare.

The exam itself is what you expect and fear: standing upright, a plate pressed against the breast, the breast pulled through a clear aperture and compressed between two paddles, one view, then turned and done again. For a bilateral screening it is four views. It hurts for about a second and a half. The technologist will rotate you and ask you to hold still and stop breathing; if the images are not good enough she will redo the view, which is annoying rather than dangerous. Tell her before you start if you have had a previous

mammogram that was hard to read, because the positioning she chooses should account for it.

The dose is genuinely low. A two-view screening exam sits well below a chest computed tomography scan in radiation terms, and the unit displays the dose it delivered in milligray with the images. If you are pregnant or possibly pregnant, say so before the exam — that is the one hard rule, and it is not negotiable. Mammography is not done in pregnancy unless the diagnostic question is urgent, and every radiology department in China will ask you the question first.

When the Report Says BI-RADS 4 or 5: Work-up and Biopsy

The ultrasound or mammogram report will come back with a BI-RADS category, which is the radial scoring system used in Chinese hospitals exactly as it is used everywhere else. It runs from 0 to 6:

1. BI-RADS 0 — incomplete. Needs another view or another test before anything can be said. Extremely common on a first screening, and not a scare: it usually just means “we want a fourth view” or “we want an ultrasound of that area”.
2. BI-RADS 1 — normal. Nothing to see.
3. BI-RADS 2 — benign. A cyst, a simple fibroadenoma, a calcified scar. You go back to routine screening.
4. BI-RADS 3 — probably benign. Short-interval follow-up, typically at six months, rather than a biopsy.
5. BI-RADS 4 — suspicious. Subdivided into 4a, 4b and 4c by how suspicious it looks. This is the number that leads to a biopsy.
6. BI-RADS 5 — highly suggestive of malignancy. Biopsy, and usually quickly.
7. BI-RADS 6 — known malignancy, already proven, now for staging and treatment planning.

A radiologist who reads a BI-RADS 4 will write the finding in two sentences: where it is, what it measures, and what shape and margins it has. You will get a copy of the report in Chinese. The Chinese wording of these findings is roughly standard — jie-jie for nodule, zhuang-kua for mass, bian-jie bu-qing for indistinct margins, and wei-xiao gai-hua for microcalcification — and if you want to follow the conversation, those four words cover most of what you will hear. Ask for an English printout at the desk when you collect it; it is a reasonable request and most departments will do it, though the official record stays in Chinese.

The next step is usually a core needle biopsy, done by the surgeon or an interventional radiologist under ultrasound guidance, and it is worth understanding because it is far less of a production than people imagine.

You lie down on a procedure couch in a small room next to the ultrasound machine. A radiologist marks the spot on your skin with a pen, the skin is cleaned and numbed with a local anaesthetic, and a spring-loaded needle with a side notch is fired into the lesion — a handful of times, collecting several small cylinders of tissue, maybe forty seconds of pressure. The cylinder fragments are put in a jar of formalin and sent to the pathology lab. Most hospitals keep the patient in the recovery area for twenty to thirty minutes and send her home. You can drive yourself if you are comfortable; the anaesthetic is local and there is no general anaesthetic involved. The bruising takes a week or two to fade and the area is sore to press for a few days. Some surgeons give a prophylactic antibiotic, some do not, and either is defensible.

Two alternatives exist and are used selectively. Vacuum-assisted biopsy removes a larger specimen through the same needle path and is used for small lesions where you would otherwise lose the target; it costs more and is sometimes done under local anaesthetic in the same room. And for a lesion that cannot be felt or seen well on the images — an impalpable spicule — the surgeon places a marker wire or a radioactive seed in the breast under image guidance beforehand, and the specimen is removed in the operating theatre the following day. That is the only breast procedure in this list that requires a theatre, and it is not as common as it sounds.

One sentence of honesty, because these articles tend to imply otherwise: a biopsy gives you a diagnosis. It gives you a diagnosis on the day it is reported, and that diagnosis then gets staged and treated. It does not tell you what will happen in five years, and it does not tell you that surgery or medication will hold anything at bay. Anyone who uses the words “cure” or “guaranteed” in an advertisement for a breast clinic in China is breaking the same rules that apply in every other market.

The Path Report, Decoded

The pathology report is the document that actually governs everything downstream, and it is written in language that assumes you know the vocabulary. Part of it is straightforward: the site, the histology, the grade. The rest requires a short glossary.

You will see terms such as invasive ductal carcinoma, invasive lobular carcinoma, ductal carcinoma in situ, mucinous carcinoma, tubular carcinoma — these are the histologic types, and they are the same names your pathologist at home used. The report will also carry a Nottingham grade for invasive disease, which describes how the cells look under the microscope, and the TNM stage, which describes the size of the primary tumour, whether nodes were involved and whether there was distant disease at diagnosis. Chinese pathology reports use the WHO classification and the AJCC staging conventions; the report is internally consistent even when the English on the page is rough.

Then the immunohistochemistry block, which is the part that changes the treatment plan:

• ER and PR — oestrogen and progesterone receptor status. If positive, the tumour is hormone-receptor positive and endocrine therapy becomes an option.
• HER2 — human epidermal growth factor receptor 2. If it is positive, HER2-directed therapy becomes an option. This is where the Chinese drug supply story matters: trastuzumab has been approved by the National Medical Products Administration for years, biosimilar versions are on the market, and pertuzumab is available at the major cancer centres. Approval and availability are not the same thing as affordability, which I will come back to.
• Ki-67 — a proliferation marker that describes how fast the cells are dividing, expressed as a percentage. It is one of the numbers that feeds the discussion about chemo.

Put those together and the surgeon or oncologist may describe your disease as a subtype — luminal, HER2-positive, triple negative, or luminal B. That is shorthand for a group of treatment choices, not a prediction, and no doctor should present it as one.

Turnaround is three to five working days for the histology itself, longer if the case needs extra immunohistochemistry or a second look — a week to ten days is normal for a complex one. Ask at the time of the biopsy when you can collect, because the dates differ by hospital and the assumption that you will get it on the same day is wrong everywhere.

From Diagnosis to Treatment: The Multidisciplinary Meeting

If the biopsy shows cancer, the single biggest practical difference between a general tertiary hospital and a dedicated cancer centre shows up here, in the meeting room rather than the clinic.

Chinese cancer centres run multidisciplinary team meetings — the MDT, as they call it — where the surgeon, the oncologist, the radiologist, the pathologist, the radiation oncologist and sometimes the plastic surgeon and the nutritionist sit with the patient’s images and slides in front of them and agree a plan before anyone operates. Peking University Cancer Hospital, the cancer hospital of the Chinese Academy of Medical Sciences in Beijing, Fudan University Shanghai Cancer Center, Sun Yat-sen University Cancer Center in Guangzhou, Zhejiang Provincial Cancer Hospital in Hangzhou and the provincial medical centres in Guangdong and Shenzhen all run such meetings, and the quality of the discussion is comparable to anywhere. What differs is the queue in front of it.

The plan usually involves several of the following, and the order is not fixed:

1. Surgery — either breast-conserving surgery with a segmental resection and a sentinel node biopsy, or a mastectomy. Whether one or the other is discussed depends on the tumour size, the position, and your own preference, which is taken seriously and recorded. Sentinel node biopsy is the standard way of avoiding a full axillary dissection when the nodes look quiet, and it is performed at the big centres.
2. Radiotherapy — for most breast-conserving surgery, and after some mastectomies. The radiotherapy department is a separate building with its own queues, and scheduling it is often the slowest part of the timeline.
3. Systemic therapy — chemotherapy, endocrine therapy, HER2-directed therapy, or some combination. Neoadjuvant means before surgery; adjuvant means after.
4. Reconstruction — if you have a mastectomy and want reconstruction, it is discussed as part of the surgical plan, either at the same operation or staged later. This is reconstructive surgery after a cancer procedure, not cosmetic surgery, and it belongs in the conversation with your surgeon rather than in a beauty clinic’s brochure.
5. Follow-up — a schedule, usually every three to six months for the first years, with imaging that is deliberately kept on the same machine so the pictures can be compared.

Realistically, once the biopsy is in hand: the MDT convenes between three and ten working days, surgery is listed one to three weeks after that at a busy centre, and a full course of treatment runs into several months. If you are planning to fly home between steps, agree the sequencing with the surgeon before you book the flight, because the gap between the end of one block of treatment and the start of the next is rarely something anybody can hold a ticket open for.

There is also a second-opinion route, which is one of the more underused things on offer. The bigger centres are comfortable being asked for a review of a case you have already worked up, and bringing a pathology slide plus the imaging is often more useful than bringing the report. It is not the same as being treated there, and it does not require you to say which hospital you think is best.

Genetic Testing, BRCA Panels, and Taking Results Home

Genetic testing for breast and ovarian cancer risk is available in China, mostly through hospital genetics clinics or accredited third-party laboratories, and it is worth knowing both what it involves and — this is the part almost nobody tells foreign patients — what the rules are about taking it out of the country.

The common test looks at BRCA1 and BRCA2, the two genes most often discussed in families with breast and ovarian cancer, and increasingly a broader panel that covers a dozen or more genes related to breast, ovarian, pancreatic and prostate cancer risk. Sample: blood, sometimes saliva. Turnaround: two to four weeks, and longer if the lab has to sequence a panel rather than screen the two known genes. Cost in a private outpatient channel: roughly RMB 3,000 to 8,000 depending on how broad the panel is. Genetic counselling before and after is part of the service at the better clinics, and you should insist on it — a raw variant result without counselling is worse than no result.

Now the part that catches people out. China regulates the export of human genetic resources. Since the regulations on the management of human genetic resources took effect in 2019, providing or exporting human genetic materials from China — blood, tissue, DNA extraction, and the associated data — outside the country generally requires review and approval through the competent authority, and hospitals carrying out this kind of work are expected to have gone through their own internal review. If you are tested in China and then want your data or your samples handed to a laboratory abroad, the honest answer is that this is not a simple courier question. Ask the hospital’s research office or ethics committee before you consent to any testing that might be sent somewhere else, and ask in writing if you can.

The same logic applies, more loosely, to your medical records. Personal information about your health is treated as sensitive personal information under Chinese data protection law, and cross-border transfer of it is regulated. In practice this affects you mostly in one direction: you want your own records. You are entitled to them, and asking is not a legal grey area. Taking your own documents out of the country for your own care is normal and should not be framed as a violation. But expect the hospital to hand you paper or a CD rather than email a database export, and expect the electronic report system to be built around Chinese phone numbers and WeChat, which you may not have.

If you already know you want testing at home, do the testing at home. It is simpler, your own genetics team can counsel you in your language, and you will not be explaining to a Shenzhen research office why your sample needs to leave the country. If you are tested in China, get a printed report, the laboratory accession number, and the clear statement of what gene and what variant was reported. A phone photograph of a path report is worth nothing six months later.

What Breast Screening Costs, and How Foreign Patients Pay

Everything below is an estimate in renminbi for a foreign outpatient paying self-care rates at a public tertiary hospital in a first-tier city in 2026. It is a map of the price, not a quote. Estimates only — final costs are determined by the hospital.

• Registration and consultation at a specialist clinic: roughly RMB 30 to 100 for the consultation fee; a general clinic is closer to RMB 15 to 30.
• Bilateral breast ultrasound with axilla, reported in BI-RADS terms: roughly RMB 150 to 350.
• Two-view screening mammogram: roughly RMB 250 to 500. A diagnostic four-view study with tomosynthesis: roughly RMB 600 to 1,200.
• Breast MRI with contrast, used selectively for dense breasts, extent assessment or implant evaluation: roughly RMB 900 to 1,600.
• Ultrasound-guided core needle biopsy including the histology: roughly RMB 1,500 to 3,500. Vacuum-assisted biopsy: roughly RMB 3,000 to 6,000.
• Immunohistochemistry panel added to a path report: roughly RMB 300 to 900.
• BRCA or multi-gene panel with counselling: roughly RMB 3,000 to 8,000, two to four weeks.
• If treatment follows: lumpectomy with sentinel node biopsy roughly RMB 15,000 to 30,000; mastectomy roughly RMB 25,000 to 50,000; a full radiotherapy course roughly RMB 25,000 to 60,000; systemic therapy per cycle roughly RMB 3,000 to 12,000 for conventional regimens and considerably more when HER2-directed agents are included.

Payment mechanics matter because they are where foreign patients lose an afternoon. Most Chinese public hospitals accept WeChat Pay and Alipay, which need a Chinese-linked wallet; foreign credit and debit cards work at the cashier in the larger urban hospitals, though the terminal is not always at the same counter as the one you registered at. Cash in renminbi is always accepted and is quietly the fastest route. If you are admitted, the hospital asks for a deposit on admission and settles against it, so ask the financial counter for a written deposit statement and keep every slip.

Keep the invoices. If an overseas insurer or an employer is going to reimburse you, the documents it wants are a formal hospital invoice itemised by charge, a discharge summary if you are admitted, and a copy of the pathology report — all three in one folder, all three with your name spelled the same way as on your passport. Chinese hospitals issue the official invoice (fapiao) at the cashier; the itemised list underneath it is what the claims team actually reads. Photograph each one the day you get it. Paper in a backpack in a humid city does not survive a year, and which documents a claims team will actually accept is set out item by item in our own page on hospital invoice reimbursement in China.

Going Home With Your Results: Records, Slides and the Realistic Follow-Up

The records office — the bing-an-shi, which on the door in English is usually just “Medical Records” — is the last stop, and it is where most foreign patients either do the right thing or quietly lose the thing that would have been useful.

Ask for three things: a printed copy of every report, the images on a disc or a USB stick in DICOM format with a small viewer program, and a short letter in English summarising what was found and what was done. Under Chinese hospital rules you can request copies of your own records, and you will need to show your passport and, in many hospitals, complete the records-copying form at the desk. Expect a modest copying fee, expect the English letter to be written on the hospital’s letterhead by whoever has time, and expect the process to take the better part of a morning.

The imaging disc is the most valuable object you will leave with, because a picture from a machine you will never see again is far more useful to your own radiologist than any written description of it.Label it with your full name, passport number, date and hospital. A CD in a plastic wallet in a folder costs nothing and saves you re-running the whole work-up in another country.

The slides are the awkward one. Paraffin-embedded tissue blocks are not something an ordinary courier will carry internationally, and sending them out of China raises the same human-genetic-resource questions that came up with the genetic testing. In practice, the path toward an outside review is: ask the pathology department whether stained slides can be released, ask whether they will courier them or whether you carry them in your cabin, and if the answer is no, ask whether the hospital will do the review itself and give you a report. Several centres are used to this request from returning patients and will tell you straight away what is possible. Do not let a month go by before asking; the answer depends on people, and people have holidays.

Then the practical matter of returning. If your follow-up imaging is scheduled in China and you need to be here for it, the visa question comes before the appointment question, because the appointment will outlast whatever you currently hold. Extending or switching visa category is a filled form and a queue, not a phone call, and doing it late is how people end up in the awkward position of being here without the right status to be here. Bring the appointment printout with the date on it; it helps.

And when you do sit down with your own doctor at home with that envelope of paper and that disc: the Chinese report will be thorough on what was found and terse on interpretation, which is the normal shape of a pathology report everywhere. Being translated is not the same as being explained. Your own surgeon needs the images, the histology and the immunohistochemistry, and those three are what will actually be read.

Frequently Asked Questions

How long does a breast screening appointment take in China?

From arrival at the lobby to leaving with an imaging order: two to four hours is normal at a busy tertiary hospital in Shenzhen or Guangzhou, longer if radiology is queued. The consultation with the surgeon is short — ten to fifteen minutes — and the waiting is registration, the queue in the clinic, and the imaging itself. Book the first slot of the day if you are on a tight schedule, because the clinic’s full list is usually known by nine and the last appointments of the morning are the ones that get squeezed to four minutes.

Can I get a mammogram if I am under forty and came from overseas?

Yes, but you will probably be told that the ultrasound comes first. Mammography is used in younger women when there is a symptom, a dense breast that ultrasound could not fully assess, a family history that raises the question, or a finding that needs a second look from a different angle. Ask the surgeon directly why she has ordered one rather than the other; a clear answer takes fifteen seconds and tells you whether she is thinking about your density or your risk.

Will my Chinese hospital records be accepted by my doctor at home?

The documents are accepted; the language needs handling. Chinese hospitals issue the reports in Chinese, and you can request an English printout, but the official record stays in Chinese. What your doctor at home actually wants is the imaging on a disc plus the pathology report with the immunohistochemistry — those travel fine and read fine once opened. If you want the narrative explained before you fly, ask the hospital for a one-page English summary at the same time you collect the records.

Can I take my biopsy samples or genetic test results out of China?

The reports and the discs yes, with no drama. The raw tissue is the difficult part: sending biological samples or genetic data out of China falls under the human genetic resource rules, and the hospital’s research or ethics office has to be asked before anything leaves. Stained slides and the written report are normally what an outside reviewer works from, and several big centres do that review themselves and hand you the answer. Ask early, in writing, and do not make travel plans that depend on an answer you do not yet have.

A Note on Scope

This page is written by Karl Huang, technical director of Tianyou Medical Research Institute, a certified health manager and a China-based medical escort, and advisory consultant to Zhong’an Kanghua Clinic. Some of the material here comes from work done alongside clinicians in Chinese public hospitals; where this article describes anything resembling a service offered by Zhong’an Kanghua Clinic, that relationship is disclosed plainly in the text and I do not present any of it as a treatment promise or a statement about outcomes. Nothing in this article should be read as a claim that any hospital, clinic, medicine or procedure will prevent, cure or control breast disease, and nothing here is a substitute for a consultation with a qualified doctor about your own case.

Costs quoted are estimates only — final costs are determined by the hospital. Drug and device availability described here reflects the regulatory position in China as published by the National Medical Products Administration and the National Health Commission, and it changes; always confirm the current status with the hospital before you rely on it. Radiation, contrast and anaesthetic advice given here is general information, not a protocol for you personally: if you are pregnant, breastfeeding, allergic to contrast, or taking medications that interact, tell the examining clinician before the test, not after. This article does not constitute medical advice, and no clinician-patient relationship is created by reading it.

If you want the site’s position on how these pages are researched and reviewed, read the Editorial Policy. If you want what we mean by medical information here and what we will not claim, the Medical Disclaimer sets that out.